Big4Bio:SFBay

@Big4BioSF

Part of the life science hub coverage network. Subscribe to the Big4Bio:SFBay daily newsletter for FREE:

Vrijeme pridruživanja: prosinac 2013.

Tweetovi

Blokirali ste korisnika/cu @Big4BioSF

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Big4BioSF

  1. prije 3 sata

    With funding from Gilead Sciences, Cardinal Health, Canaan Partners, and others, Vineti is planning to channel its software into making safer and more accessible for patients.

    Poništi
  2. proslijedio/la je Tweet
    4. velj
    Poništi
  3. proslijedio/la je Tweet
    Poništi
  4. prije 4 sata

    Listen to Nkarta Therapeutics' CSO James Trager talk about the company's platform on February 18, 2020.

    Poništi
  5. proslijedio/la je Tweet
    prije 7 sati

    Stanford researchers ID cells that transform into tissue that caps off plaque in atherosclerosis. They also believe they’ve found the gene responsible for transformation.

    Poništi
  6. 4. velj

    "By combining Santen’s expertise and Verily’s advanced technology, our joint venture is well-positioned to tackle innovative projects spanning ophthalmic conditions, such as glaucoma and dry eye."

    Poništi
  7. proslijedio/la je Tweet
    4. velj

    What is biotech, & how is it revolutionizing our approach to human health? Experts weigh in on biotech’s accomplishments & the potential for new advancements to change our approach to human health. CBF is proud to have contributed to this effort with :

    Poništi
  8. proslijedio/la je Tweet
    4. velj

    Announcing Bio Fund III: $750m to support entrepreneurs at intersection of tech + biotech addressing our biggest challenges—from intractable disease + an overburdened healthcare system, to how we reshape our world

    Poništi
  9. 4. velj

    With the help of bonds issued by the state, CIRM could give out $5.5 billion more in grants to California researchers.

    Poništi
  10. proslijedio/la je Tweet
    4. velj

    The location of damaged astrocytes — a crucial support cell in the ’s brain - may hold the key to understanding what drives distinct symptoms in patients with the disease.

    Poništi
  11. 4. velj

    "Never before have patients with chronic pain had the opportunity to walk around and deliver neural data in real time."

    Poništi
  12. proslijedio/la je Tweet
    3. velj

    Gilead publicly floated the idea of using remdesivir to treat the coronavirus, dubbed 2019-nCoV, 10 days ago. Since then, the effort to advance the drug in the indication has gathered pace.

    Poništi
  13. 3. velj

    Here's a flashback to 2019's biggest stories, financial deals, and more! Download a copy of 's Year-in-Review report for the SF Bay sector!

    Poništi
  14. proslijedio/la je Tweet

    The Chan Zuckerberg Initiative is announcing 30 grants to patient groups — with the goal of building a model for tackling any rare disease. My story:

    Poništi
  15. 31. sij

    Here's the first-ever Year-in-Review report for the SF Bay sector! Inside the 2019 issue, you can read facts about the industry, financial deals and more!

    Poništi
  16. 31. sij

    Brain organoid models, widely propounded as "brains in a dish," do not posses either the basic features or structural complexity of an actual brain.

    Poništi
  17. 31. sij

    "We weren’t originally planning to create a material useful for photothermal therapy, but found that the ionic polymer we made also strongly absorbs near-infrared light."

    Poništi
  18. proslijedio/la je Tweet
    30. sij
    Poništi
  19. 30. sij
    Poništi
  20. 30. sij
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·